scispace - formally typeset
Search or ask a question
Topic

Withania somnifera

About: Withania somnifera is a research topic. Over the lifetime, 2116 publications have been published within this topic receiving 43404 citations. The topic is also known as: Ashwaganda & Indian ginseng.


Papers
More filters
Journal ArticleDOI
TL;DR: It is concluded that basal rot of onion can be controlled by combined application of W. somnifera dry leaf material and biological control agent T. harzianum.
Abstract: Onion is attacked by destructive soil-borne fungal plant pathogen Fusarium oxysporum f. sp. cepae, resulting in basal rot disease. In the present study, three Trichoderma species (T. pseudokoningii, T. harzianum and T. reesei) and leaves of solanaceous weed Withania somnifera were used for management of this disease. The in vitro interaction study revealed T. harzianum as the most effective biocontrol agent against the pathogen. In a pot trial, dried leaf material of W. somnifera (1%, 2% and 3% w/w) and inoculum of T. harzianum were mixed in the pot soil previously inoculated with the pathogen. The highest incidence of the disease (87%) was found in positive control (pathogen inoculation without any amendment). Different rates of dry leaf material reduced the incidence of the disease to 41-66%. T. harzianum in combination with leaf material reduced the incidence of the disease to 20-53%. In a laboratory bioassay, the dry leaf extract of W. somnifera was prepared in methanol and partitioned with n-hexane, chloroform, ethyl acetate and n-butanol. The highest concentration (200 mg mL-1) of all except for the n-butanol fraction significantly decreased fungal biomass over control. This study concludes that basal rot of onion can be controlled by combined application of W. somnifera dry leaf material and biological control agent T. harzianum.

19 citations

Journal ArticleDOI
TL;DR: Initial findings indicate that Withania somnifera extract may act as an antioxidant and cholinergic modulator and may have beneficial effects in CCD and AD therapy.
Abstract: Canine cognitive dysfunction (CCD) is an age-dependent neurodegenerative condition characterised by changes in decline in learning and memory patterns. The neurodegenerative features of CCD in ageing dogs and cats are similar to human ageing and Alzheimer's disease (AD). Discovering neuroprotective disease-modifying therapies against CCD and AD is a major challenge. Strong evidence supports the role of amyloid β peptide deposition and oxidative stress in the pathophysiology of CCD and AD. In both the human and canine brain, oxidative damage progressively increases with age. Dietary antioxidants from natural sources hold a great promise in halting the progression of CCD and AD. Withania somnifera (WS), an Ayurvedic tonic medicine, also known as 'Indian ginseng' or ashwagandha has a long history of use in memory-enhancing therapy but there is a dearth of studies on its neuroprotective effects. The objective of this study was to investigate whether WS extract can protect against Aβ peptide- and acrolein-induced toxicity. We demonstrated that treatment with WS extract significantly protected the human neuroblastoma cell line SK-N-SH against Aβ peptide and acrolein in various cell survival assays. Furthermore, treatment with WS extract significantly reduced the generation of reactive oxygen species in SK-N-SH cells. Finally, our results showed that WS extract is also a potent inhibitor of acetylcholinesterase activity. Thus, our initial findings indicate that WS extract may act as an antioxidant and cholinergic modulator and may have beneficial effects in CCD and AD therapy.

19 citations

Journal ArticleDOI
TL;DR: A new, simple, accurate, and precise HPLC method for the simultaneous determination of flavonoid glycosides as unique constituents of the aerial parts, being absent in roots of the plant is described.
Abstract: Withania somnifera (L.) Dunal (Solanaceae) commonly known as ashwagandha, is an important plant in Ayurveda and is believed to increase longevity and vitality. The root is considered to be the medicinally important part of the plant as per classical texts and accordingly is the subject of most Pharmacopeial monographs. The aerial parts, being less expensive, are sometimes mixed with roots to prepare “standardized” extracts of W. somnifera, and in cases with false declaration of plant part used as roots on the certificate of analysis. The present study described a new, simple, accurate, and precise HPLC method for the simultaneous determination of flavonoid glycosides as unique constituents of the aerial parts, being absent in roots of the plant. The RSD for intra- and interday analyses was less than 2.5% and the recovery was 90–108%. The method was used to analyze samples of roots and aerial parts of the plant collected from India and Egypt. The samples of commercially available extracts of W. somnifera were also analyzed and many samples were found to contain flavonoid glycosides indicating a possible undeclared use of aerial parts in the extracts derived from roots in commercial practice.

19 citations

Journal ArticleDOI
TL;DR: Ashwagandha (Withania somnifera) root extract restored serum AST, ALT towards normal levels in gentamicin intoxicated rats which may be due to its free radical scavenging activity and may have hepatoprotective effect.
Abstract: Background: Liver is an essential metabolic organ. It can be damaged due to prolonged use and higher doses of drugs, exposure to some chemicals, toxins, or infectious agents. Herbal plants as ashwagandha (Withania somnifera) may have free radical scavenging activity thereby can be used for the prevention and treatment of liver damage. Objective: To observe the effect of ashwagandha (Withania somnifera) root extract on gentamicin induced changes of some liver marker enzymes e,g serum aspartate amino transferase (AST ) and alanine amino transferase (ALT) in Wistar albino rats. Methods: This experimental study was carried out in the Department of Physiology, Sir Salimullah Medical College (SSMC), Dhaka from 1 st July 2010 to 30 th June 2011. A total number of 35 Wistar albino rats, aged 90 to 120 days, weighing between 150 to 200 grams were selected for the study. After acclimatization for 14 days, they were divided into control group (Group A) and experimental group (Group B). Control group was again subdivided into group A 1 (baseline control, consisted of 10 rats) and group A 2 (gentamicin treated control group, consisted of 10 rats). Again, experimental group (Group B-ashwagandha pretreated and gentamicin treated group) consisted of 15 rats. All groups of animals received basal diet for 22 consecutive days. In addition to this, group A2 also received gentamicin subcutaneously (100mg /kg body weight/day) for the last eight (15 th to 22 nd day) consecutive days. Again, group B received ashwagandha root extract (500mg/kg body weight/day, orally) for 22 consecutive days and gentamicin subcutaneously (100mg/kg body weight /day) for last eight (15 th to 22 nd day) days. All the animals were sacrificed on 23 rd day. Then blood and liver samples were collected. For assessment of liver function, serum AST, ALT and bilirubin levels were estimated. All these tests were done by standard Laboratory technique. The statistical analysis was done by one way ANOVA and Bonferroni test as applicable. Results: The mean serum levels of AST and ALT were significantly (p<0.001) higher in gentamicin treated control group and in ashwagandha pretreated and gentamicin treated group in comparison to those of baseline control group.. Again, these levels were significantly (p<0.001) lower in ashwagandha pretreated and gentamicin treated group than those of gentamicin treated control group. Conclusion: Ashwagandha (Withania somnifera) root extract restored serum AST, ALT towards normal levels in gentamicin intoxicated rats which may be due to its free radical scavenging activity. Therefore it may have hepatoprotective effect. DOI: http://dx.doi.org/10.3329/jbsp.v7i1.11152 J Bangladesh Soc Physiol. 2012, June; 7(1): 1-7

18 citations

Journal ArticleDOI
TL;DR: The present review confirms the various medicinal values of W. somnifera without any significant side effects and suggests further research strategies to harness the therapeutic potential of this plant.

18 citations


Network Information
Related Topics (5)
Antioxidant
37.9K papers, 1.7M citations
79% related
Essential oil
32.6K papers, 625.2K citations
78% related
Gallic acid
9.6K papers, 287K citations
78% related
Quercetin
7.7K papers, 333.3K citations
78% related
Antibacterial activity
18.4K papers, 322.4K citations
78% related
Performance
Metrics
No. of papers in the topic in previous years
YearPapers
2023114
2022265
202188
2020124
201995
2018111